Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.

Biotechnology

Abivax

Marc De Garidel

Julien Santo

Chris Rabbat

Christine Cook

Nadege Briancon-Eris

Mary Mantock

Ana Sharma

Ida Hatoum

Michael Ferguson

Didier Scherrer

Jérôme Denis

Pierre Courteille

Didier Blondel

Scientific And Research Team

Leadership Team

Directors Team

Finance and Accounting

Medical Affairs and Clinical Operations

Project & Program Management

Commercial and Business Development

Teams at Abivax

Scientific And Research Team

Leadership Team

Directors Team

Finance and Accounting

Medical Affairs and Clinical Operations

Project & Program Management

Commercial and Business Development